Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

Pr Elfride DE BAERE

In this page

Member info

Pr Elfride DE BAERE

Substitute

Belgium

Working Group Leader: Genetic Diagnostics (TWG6)
Other Working Group(s): Retinal Rare Eye Diseases (WG1), Genetic Diagnostics (TWG6)

Team

Pr Bart LEROY

Belgium

Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), National Integration (TWG9), Research (TWG8), Retinal Rare Eye Diseases (WG1)
Working Group Leader
See more

HCP Center

The Ghent University Hospital is one of the largest and most specialized hospitals in Flanders with more than 3,000 patients a day and more than...

contact

Ghent University Hospital, Ghent, Belgium

Corneel Heymanslaan 10
9000 Ghent
Belgium

Clinical trials

NCT04855045 Unknown

An Open-Label, Dose Escalation and Double-Masked, Randomized, Controlled Study to Evaluate the Safety and Tolerability of Sepofarsen in Pediatric Subjects G (p.Cys998X) Mutation.

Interventional
See the trial
voir la fiche

NCT05566795 Recruiting, Active

A Phase 3, Randomized, International Multicenter Trial of DAY101 Monotherapy Versus Standard of Care Chemotherapy in Patients with Pediatric Low-Grade Glioma Harboring an Activating RAF Alteration Requiring First-Line Systemic Therapy

Interventional
See the trial
voir la fiche
NCT05063162 Recruiting, Active

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3, Pivotal Study With an Open-Label Extension Period to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disease (MOG-AD)

Interventional
See the trial
voir la fiche
NCT04794101 Active, Not recruiting

Phase 3 Follow-up Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

Interventional
See the trial
voir la fiche
NCT04671433 Active, Not recruiting

Phase 3 Randomized, Controlled Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

Interventional
See the trial
voir la fiche
NCT04127006 Active, Not recruiting

Rate of Progression in EYS Related Retinal Degeneration (Pro-EYS).

Observational
See the trial
voir la fiche
NCT03913143 Active, Not recruiting

A double-masked, randomized, controlled, multiple-dose study to evaluate the efficacy, safety, tolerability and systemic exposure of QR-110 in Subjects with Leber’s Congenital Amaurosis (LCA) due to c.2991+1655A>G mutation (p.Cys998X) in the CEP290 gene (Illuminate).

Interventional
See the trial
voir la fiche
NCT03140969 Completed

Study to Evaluate QR-110 in Subjects With Leber’s Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene.

Interventional
See the trial
voir la fiche
NCT03146078 Active, Not recruiting

Rate of Progression in USH2A Related Retinal Degeneration

Observational
See the trial
voir la fiche
NCT02796274 Completed

Historical Case Record Survey of Visual Acuity Data From Patients With Leber’s Hereditary Optic Neuropathy (LHON).

Interventional
See the trial
voir la fiche
NCT02544217 Completed

A Phase I, Randomized, Double Blind, Placebo-controlled, Dose-escalating Clinical Trial With KH176.

Interventional
See the trial
voir la fiche
NCT05811351 Recruiting, Active

A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Interventional
See the trial
voir la fiche
NCT05436665 Recruiting, Active

The Belgian Endothelial Surgical Transplant of the Cornea:Clinical and Patient-reported Outcomes of Descemet Stripping Automated Endothelial Keratoplasty(DSAEK) Versus Descemet Membrane Endothelial Keratoplasty(DMEK)

Interventional
See the trial
voir la fiche
NCT04295304 Terminated

Safety and Performance Evaluation of the NR600 System in Subjects With End-stage Inherited Outer Retinal Degenerative Diseases

Interventional
See the trial
voir la fiche
NCT06294613 Recruiting, Active

A Prospective, Open-label, Single-center, Study of the ACUSURGICAL Luca System for Treatment of Vitreoretinal Diseases

Interventional
See the trial
voir la fiche
NCT00481546 Active, Not recruiting

Phase I Trial of Gene Vector to Patients with Retinal Disease due toRPE65 mutations

Interventional
See the trial
voir la fiche
NCT03992417 Active, Not recruiting

A Prospective Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis

Observational
See the trial
voir la fiche

Scientific publications

Where are the missing gene defects in inherited retinal disorders? Intronic and synonymous variants contribute at least to 4% of CACNA1F‐mediated inherited retinal disorders

A comprehensive study applying direct Sanger sequencing of the gene‐coding regions, exome and genome sequencing applied to a large cohort of...

The need for widely available genomic testing in rare eye diseases: an ERN‑EYE position statement

ERN-EYE promotes access to genetic testing in RED and emphasizes the clinical need and relevance of genetic testing in...

Phenocopy of a heterozygous carrier of X-linked retinitis pigmentosa due to mosaicism for a RHO variant

We describe both phenotype and pathogenesis in two male siblings with typical retinitis pigmentosa (RP) and the potentially X-linked RP (XLRP)...

Comprehensive variant spectrum of the CNGA3 gene in patients affected by achromatopsia

We provide extensive in silico analyses and summarize reported functional data of previously analyzed missense, nonsense and splicing variants to...

Multi-omics approach dissects cis-regulatory mechanisms underlying North Carolina macular dystrophy, a retinal enhanceropathy

Van de Sompele et al. used multiomics profiling and in vitro and in vivo enhancer assays to dissect the regulatory mechanisms underlying North...

Novel Clinical Observations and Genetic Spectrum in 340 Patients

In most patients, XLRS showed a slow deterioration starting in the second decade of life, suggesting an optimal window of opportunity for...

Novel OPN1LW/OPN1MW Exon 3 Haplotype-Associated Splicing Defect in Patients with X-Linked Cone Dysfunction

Patients carrying the novel L-I-V-V-A haplotype presented with a mild form of Blue Cone Monochromacy or Bornholm Eye Disease-like phenotype with...

Optic nerve involvement in CACNA1F-related disease: observations from a multicentric case series

Our data support the hypothesis that CACNA1F could be related to early-onset or congenital optic nerve involvement without any signs of a...

Personalized genetic counseling for Stargardt disease: Offspring risk estimates based on variant severity

In this cross-sectional study, 1,619 ABCA4 variants from 5,579 individuals with STGD1 were collected and...

Recommendations for whole genome sequencing in diagnostics for rare diseases

The aim of these recommendations is primarily to list the points to consider for clinical (laboratory) geneticists, bioinformaticians, and...

The Natural History of Leber Congenital Amaurosis and ConeeRod Dystrophy Associated with Variants in the GUCY2D Gene

Leber congenital amaurosis associated with GUCY2D caused severe congenital visual impairment with relatively intact macular anatomy on funduscopy...

CEP162 deficiency causes human retinal degeneration and reveals a dual role in ciliogenesis and neurogenesis

We found that homozygosity for a truncating variant in CEP162, a centrosome and microtubule-associated protein required for transition zone...

PDF -

Cost-effective sequence analysis of 113 genes in 1,192 probands with retinitis pigmentosa and Leber congenital amaurosis

Here, we present the outcome for 1,192 probands that underwent smMIPs-based sequencing using the RP-LCA smMIPs...

PDF - 1 MB

Toward reporting standards for the pathogenicity of variant combinations involved in multilocus/oligogenic diseases

New Noncoding Base Pair Mutation at the Identical Locus as the Original NCMD/MCDR1 in a Mexican Family, Suggesting a Mutational Hotspot

We report a new noncoding mutation at the same locus (chr6:99593030G>C) involving the same DNase I site regulating the retinal transcription...

Homozygous stop mutation in AHR causes autosomal recessive foveal hypoplasia and infantile nystagmus

Herein we present a consanguineous family with three children affected by foveal hypoplasia with infantile nystagmus, following an autosomal...

Long-Term Follow-Up of Retinal Degenerations Associated With LRAT Mutations and Their Comparability to Phenotypes Associated With RPE65 Mutations

To investigate the natural history in patients with LRAT-associated retinal degenerations (RDs), in the advent of clinical trials testing...